This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Biologicals S.a.. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Silvia Silla: Innovator in Vaccine Adjuvant Compositions
Introduction
Silvia Silla is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of vaccine development, particularly through her innovative work on adjuvant compositions. Her research focuses on enhancing the efficacy of vaccines, which is crucial for public health.
Latest Patents
Silvia holds a patent for "Adjuvant compositions for vaccines." This invention pertains to improved adjuvant compositions that comprise a mixture of a saponin adjuvant, such as QS21, with monophosphoryl lipid A or its derivative, 3D-MPL, and interleukin 12. These compositions are particularly useful in a range of prophylactic and therapeutic applications, including cancer vaccines. She has 1 patent to her name.
Career Highlights
Silvia Silla has worked at SmithKline Beecham Biologicals S.A., where she has been instrumental in advancing vaccine technology. Her expertise in immunology and vaccine development has positioned her as a key figure in her field.
Collaborations
Some of her notable coworkers include Thierry Boon and Catherine Uyttenhove, who have collaborated with her on various projects related to vaccine research and development.
Conclusion
Silvia Silla's contributions to vaccine adjuvant compositions highlight her innovative spirit and dedication to improving public health through science. Her work continues to influence the field of immunology and vaccine development.